Insights

Comprehensive Manufacturing Capabilities Delpharm's extensive portfolio covers a wide range of pharmaceutical forms, including tablets, capsules, injectables, prefilled syringes, and suspensions. This diverse manufacturing expertise presents opportunities to provide tailored solutions across multiple dosage formats and innovative combinations for clients seeking reliable contract manufacturing.

Strategic Expansion and Investment Recent investments, such as the $140 million upgrade in Canada and facility expansions in France and Western Europe, indicate Delpharm's commitment to scaling production capacity and enhancing technological capabilities. These developments create prospects for sales of advanced manufacturing equipment, automation solutions, and supply chain support services.

Strong Industry Collaborations Partnerships with industry leaders like Pfizer, BioNTech, and Sandoz position Delpharm as a key provider for high-demand products, including COVID vaccines and injectables. Companies seeking to expand or outsource their fill&finish operations can explore collaboration opportunities with Delpharm’s specialized manufacturing and development centers.

Market Growth in Biopharma and Vaccines Delpharm's involvement in vaccine production and sterile injectable segments offers sales potential in biopharmaceutical manufacturing, containment systems, and sterile line equipment. As demand for biologics and vaccines continues to grow globally, supporting these pipelines can become a lucrative engagement point.

Innovation and Development Focus With dedicated development centers and capabilities for Phase 1 to 3 clinical batches, Delpharm is well-positioned to support companies in early-stage development and formulation. Services related to R&D automation, clinical trial manufacturing, and regulatory compliance present valuable upselling opportunities for partners seeking end-to-end solutions.

Delpharm Tech Stack

Delpharm uses 8 technology products and services including ICS Flow, AutoCAD, RSS, and more. Explore Delpharm's tech stack below.

  • ICS Flow
    Business Process Management
  • AutoCAD
    Cad & Graphics
  • RSS
    Content Management System
  • SQL
    Database
  • Ennov
    Enterprise Content Management
  • Chart.js
    Javascript Graphics
  • reCAPTCHA
    Security
  • X-XSS-Protection
    Security

Media & News

Delpharm's Email Address Formats

Delpharm uses at least 1 format(s):
Delpharm Email FormatsExamplePercentage
First.Last@delpharm.comJohn.Doe@delpharm.com
93%
FLast@delpharm.comJDoe@delpharm.com
3%
Last.First@delpharm.comDoe.John@delpharm.com
3%
First.MiddleLast@delpharm.comJohn.MichaelDoe@delpharm.com
1%

Frequently Asked Questions

Where is Delpharm's headquarters located?

Minus sign iconPlus sign icon
Delpharm's main headquarters is located at 9 Face au Boulogne-billancourt, Île-de-france 92100 France. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Delpharm's phone number?

Minus sign iconPlus sign icon
You can contact Delpharm's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Delpharm's official website and social media links?

Minus sign iconPlus sign icon
Delpharm's official website is delpharm.com and has social profiles on LinkedInCrunchbase.

What is Delpharm's NAICS code?

Minus sign iconPlus sign icon
Delpharm's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Delpharm have currently?

Minus sign iconPlus sign icon
As of April 2026, Delpharm has approximately 3.9K employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: N. R.Chief Scientific Officer Delpharm: J. D.Chief Quality Officer: D. B.. Explore Delpharm's employee directory with LeadIQ.

What industry does Delpharm belong to?

Minus sign iconPlus sign icon
Delpharm operates in the Pharmaceutical Manufacturing industry.

What technology does Delpharm use?

Minus sign iconPlus sign icon
Delpharm's tech stack includes ICS FlowAutoCADRSSSQLEnnovChart.jsreCAPTCHAX-XSS-Protection.

What is Delpharm's email format?

Minus sign iconPlus sign icon
Delpharm's email format typically follows the pattern of First.Last@delpharm.com. Find more Delpharm email formats with LeadIQ.

Delpharm

Pharmaceutical ManufacturingÎle-de-france, France1001-5000 Employees

Delpharm is a worldwide leader in contract manufacturing and development of medicines with : 
- 19 plants in France, Italy, Canada, Poland and The Netherlands
- Over 1,1 billion euros turnover
- Over 6,500 people
- 6,500 people working in the company
- Most dosage forms produced

For over 35 years, Delpharm has grown by progressively acquiring production plants, notably from major pharmaceutical laboratories. Today, Delpharm operates 18 industrial sites and 3 development centers located in France, Italy, Canada, the Netherlands, and Poland, producing over one billion boxes of medicines per year and contributing to the development of numerous projects.

As multi-specialists, Delpharm is able to supply the majority of pharmaceutical forms available on the market, such as tablets and capsules, bottles and injectable ampoules, prefilled syringes, freeze-drying, suspensions, solutions, ointments and soft gel capsules.

Delpharm also offers full development services for a wide range of pharmaceutical forms, chemical entities and innovative combinations, including the production of phase 1 to 3 clinical batches for solid, semi-solid, liquid and injectable forms.

Section iconCompany Overview

Headquarters
9 Face au Boulogne-billancourt, Île-de-france 92100 France
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

Section iconFunding & Financials

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.